HealthDaily digest, November 3, 2026
AI Healthcare Regulation in Flux: Federal Collaboration and Shifting Oversight
U.S. regulators are reshaping how artificial intelligence is controlled in healthcare, with the FDA and CMS seeking to work with states on new frameworks while certification requirements for health IT systems are being loosened. These parallel moves reflect tensions between reducing barriers for AI adoption and ensuring patient safety across the sector.
FDA and CMS Team Up with States to Build AI Oversight Framework
The FDA and CMS are exploring ways to collaborate with state governments to create regulatory approaches for health AI, including protections that shield physicians from liability for AI-assisted decisions. This coordinated effort aims to provide hospitals and doctors with clear guidance and legal certainty as they adopt AI tools.
Why it matters: Clear regulatory guidance and liability protections are essential for hospitals and doctors to adopt AI tools safely and with legal certainty.
Sources: STAT News
Reduced Certification Requirements Put AI Safety Burden on Hospitals
The U.S. Department of Health and Human Services is easing health IT certification requirements, which lowers costs for software developers but means individual health systems must now independently assess whether AI tools are safe and effective. Healthcare organizations will need stronger internal expertise to evaluate AI without centralized government standards, potentially leading to inconsistent patient protections across different hospitals.
Why it matters: Healthcare organizations will need stronger internal expertise to evaluate AI safety without centralized government certification standards, potentially creating uneven protection for patients.
Sources: MedCity News